Abstract
Leukemia is the most common malignancy that affects children, accounting for approximately one-third of cancer diagnoses. It may be defined as a neoplastic disease that affects the blood-forming tissues of the bone marrow, lymph nodes, and spleen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Academy of Pediatrics Committee on Fetus and Newborn (2003) Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on Fetus and Newborn. Pediatrics112(1 Pt 1):191–192
Ahmad K (2002) Agent Orange no longer linked to childhood AML. The Lancet Oncology 3(4):199
Alexander FE, Boyle P, Carli PM, Coebergh JW, Ekbom A, Levi F, McKinney PA, McWhirter W, Michaelis J, Peris-Bonet R, Petridou E, Pompe-Kirn V, Plesko I, Pukkala E, Rahu M, Stiller CA, Storm H, Terracini B, Vatten L, Wray N (1999) Population density and childhood leukaemia: results of the EUROCLUS Study. European Journal of Cancer 35(3):439–444
Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO (2007) Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatric Blood Cancer 48(5):555–560
Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn ERM (2003) Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. Journal of Experimental Medicine 197(10):1385–1390
Auvinen A, Kurttio P, Pekkanen J, Pukkala E, Ilus T, Salonen L (2002)Uranium and other natural radionuclides in drink ing water and risk of leukemia: a case-cohort study in Fin land. Cancer Causes and Control 13(9):825–829
Barredo J, Devidas M, Lauer S, Billett A, Marymount M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey K (2006) Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. Journal of Clinical Oncology 24(19):3142–3149
Bener A, Hoffmann GF, Afify Z, Rasul K, Tewfik I (2008) Does prolonged breastfeeding reduce the risk for childhood leukemia and lymphomas? Minerva Pediatrica 60(2): 155–161
Bergh T, Ericson A, Hillensjo T, Nygren KG, Wennerholm UB (1999) Deliveries and children born after in-vitro fertilization in Sweden 1982–1995: a retrospective cohort study. Lancet 354(9190):1579–1585
Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL (2002) Racial and ethnic differences in survival of children with acute lymphoblastic leukemia. Blood 100(6):1957–1964
Boutou O, Guizard AV, Slama R, Pottier D, Spira A (2002) Population mixing and leukaemia in young people around the la Hague nuclear waste reprocessing plant. British Journal of Cancer 87(7):740–745
Brown P, Smith FO (2008) Molecularly targeted therapies for pediatric acute myeloid leukemia: progress to date. Paedi-atric Drugs 10(2):85–92
Champagne MA, Capdeville R, Krailo MWQ, Peng B, Rosamilia M, TherrienM,ZoellnerU,BlaneySM,BernsteinM(2004)Ima-tinib mesylate (STI571) for the treatment of children with Philadelphia chromosome-positive leukemia: results from a children's oncology group phase 1 study. Blood 104(9): 2655–2660
Chessells JM, Harrison G, Richards SM, Gibson BE, Bailey CC, Hill FG, Hann IM (2002) Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI. British Journal of Haema-tology118(2):445–455
Couto E, Chen B, Hemminki K (2005) Association of childhood acute lymphoblastic leukemia with cancers in family members. British Journal of Cancer 93(11):1307–1309
Deininger M, Buchdunger E, Druker BJ (2005) The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 105(7):2640–2653
Dickinson HO, Hammal DM, Dummer TJB, Parker L, Bithell JF (2003)Childhood leukaemia and non-Hodgkin's lym- phoma in relation to proximity to railways. British Journal of Cancer 88(5):695–698
Doll R, Wakeford R (1997) Risk of childhood cancer from fetal irradiation. The British Journal of Radiology 70:130–139
Druker J, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reifers J, Cornelissen JJ, Hughes T, Agis H, Fisher T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (2006) Five year follow-up of patients receiving imatinib for chronic myeloid leukemia. New England Journal of Medicine 355(23):2408–2417
Eden OB, Harrison G, Richards S, Lilleyman JS, Bailey CC, Ches-sells JM, Hann IM, Hill FG, Gibson BE, on behalf of Medical Research Council Childhood Leukaemia Working Party (2000) Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lympho-blastic leukaemia, 1980–1997. Leukemia 14(12):2307–2320
Egeler RM, Annels NE, Hogendoorn PC (2004) Langherhans cell histiocytosis: a pathological combination of oncogen-esis and immune dysregulation. Pediatric Blood Cancer 42(5):401–403
Engel A, Lamm SH (2008) Arsenic exposure and childhood cancer-a systematic review of the literature. Journal of Environmental Health 71(3):12–16
Freedman MH (1994) Chronic myelocytic leukemia in infancy and childhood. In: Pochedly C (ed) Neoplastic diseases of childhood, vol 1. Harwood Academic, Switzerland
Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk B, Relling MV, Evans WE, Boyett JM, Pui CH (2000) Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblas-tic leukemia. Blood 96(10):3381–3384
Gaynon P (2005) Childhood acute lymphoblastic leukemia and relapse. British Journal of Hematology 131:579–587
Greaves MF,Maia AT, WiemelsJL, Ford AM (2003) Leukemia in twins: lessons in natural history. Blood 102(7):2321–2333
Grifo AH (2009) Langerhans Cell Histiocytosis in Children. Journal of Pediatric Oncology 26(1):41–47
Harned TM, Gaynon P (2008) Relapsed acute lymphoblastic leukemia: current status and future opportunities. Current Oncology Reports 10(6):453–458
Hasle H, Clemmensen IH, Mikelsen M (2000) Risks of leukemia and solid tumours in individuals with Down's syndrome. Lancet 355(9199):165–169
Head DR (2002) Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Current Opinion in Oncology 14(1):19–23
Histiocytosis Association of America (2009) LCH in Children.http://www.histio.org/site/c.kiKTL4PQLvF/b.1764433/k.8BCD/LCH_in_Children.htm. Accessed 09 January 2009
Jarup L, Briggs D, de Hoogh C, Morris S, Hurt C, Lewin A, Maitland I, Richardson S, Wakefield J, Elliott P (2002) Cancer risks in population living near landfill sites in Great Britain. British Journal of Cancer 86(11):1732–1736
Jeha S, Gandhi V, Chan KW, McDonald L, Ramirez I, Madden R, Rytting M, Brandt M, Keating M, Plunkett W, Kantarjian H (2004) Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemia. Blood 103(3):784–789
Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, Kaste S, Meacham LR, Mahajan A, Stovall M, Yasui Y, Robison LL, Sklar CA (2008) Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. Journal of Clinical Oncology 26(18):3038–3045
Kaatsch P, Mergenthaler A (2008) Incidence, time trends and regional variation of childhood leukaemia in Germany and Europe. Radiation Protection Dosimetry 132(2):107–113
Kinlen LJ (1995) Epidemiological evidence for an infective basis in childhood leukaemia. British Journal of Cancer 71(1):1–5
Klip H, Burger CW, de Kraker J, van Leeuwen FE, OMEGA-proj-ect group (2001) Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Human Reproduction 16(11):2451–2458
Knox EG (2006) Roads, railways, and childhood cancers. Journal of Epidemiology and Community Health 60(2):136–141
Kwan ML, Metayer C, Crouse V, Buffler PA (2007) Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. American Journal of Epidemiology 165(1):27–35
Lancashire RJ, Sorahan T, OSCC (2003) Breastfeeding and childhood cancer risks: OSCC data. British Journal of Cancer 88(7):1035–1037
Lee KM, Ward MH, Han S, Ahn HS, Kang HJ, Choi HS, Shin HY, Koo HH, Seo JJ, Choi JE, Ahn YO, Kang D (2009) Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk. Leukemia Research 33(2):250–258
Lightfoot T, Bunch K, Ansell P, Murphy M (2005) Ovulation induction, assisted conception and childhood cancer. European Journal of Cancer 41(5):715–724
Ma X, Buffler PA, Gunier RB, Dahl G, Smith MT, Reinier K, Reynolds P (2002) Critical windows of exposure to household pesticides and risk of childhood leukemia. Environmental Health Perspective 110(9):955–960
MacArthur AC, McBride ML, Spinelli JJ, Tamaro S, Gallagher RP, Theriault G (2008) Risk of childhood leukemia associated with parental smoking and alcohol consumption prior to conception and during pregnancy: the cross-Canada childhood leukemia study. Cancer Causes Control 19(3): 283–295
Madureira ABM, Rocha V, Teira P, Champagne M, O'Brien TA, Vora A, Stein J, Olive T, Bonfim CS, Stary J, Bertrand Y, Garnier F, Ionescu I, Niemeyer C, Gluckman E, Locatelli F (2007) Unrelated cord blood transplantation for children with JMML. Bone Marrow Transplantation 39(Suppl 1):10
Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S, Iizuka S, Koike K, Yanai F, Kawasaki K, Yanagi-machi M, Kikuchi A, Ohtusuka Y, Hidaka E, Yamauchi K, Tanaka M, Yanagisawa R, Nakazawa Y, Shiohara M, Manabe A, Kojima S, Koike K (2007) Spontaneous improvement of hematologic abnormalities in patients having juvenile myleomonocytic leukemia with RAS mutations. Blood 109: 5477–5480
MattanoLA,HarlandNS,TriggME,Nachman JB (2000) Osteone-crosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Journal of Clinical Oncology 18(18):3262–3272
McClain KL (2005) Drug therapy for the treatment of langer-hans cell histiocytosis. Expert Opinion on Pharmacother-apy 6:2435–2441
McKinney PA, Feltbower RG, Parslow RC, Lewis IJ, Picton S, Kinsey SE, Bailey CC (1999) Survival from childhood cancer in Yorkshire, UK: Effect of ethnicity and socio-economic status. European Journal of Cancer 35(13):1816–1823
McKinney PA, Feltbower RG, Parslow RC, Lewis IJ, Glaser AW, Kinsey SE (2003) Patterns of childhood cancer by ethnic group in Bradford, UK 1974–1997. Eur J Cancer. 39(1):92–7
Mellemkjaer L, Alexander F, Olsen JH (2000) Cancer among children of parents with autoimmune diseases. British Journal of Cancer 82(7):1353–1357
Menegaux F, Ripert M, Hémon D, Clavel J (2007) Maternal alcohol and coffee drinking, parental smoking and childhood leukaemia: a French population-based case-control study. Paediatric and Perinatal Epidemiology 21(4):293–299
Mizutani S (1998) Recent advances in the study of the hereditary and environmental basis of childhood leukemia. Int J Hematol. 68(2):131–43
Millot F, Brice P, Phillipe N, Thyss A, Demeoq F, Wetterwald M, Boccara JM, Vilque J-P, Guyotat D, Guilhot J, Guilhot F (2002)a-Interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia. Journal of Pediatric Hematology/Oncology24(1):18–22
Naumburg E, Bellocco R, Cnattinigius S, Jonzon A, Ekbom A (2000) Prenatal ultrasound examinations and risk of childhood leukaemia: case-control study. British Medical Journal 320(7230):282–283
Naumburg E, Bellocco R, Cnattinigius S, Jonzon A, Ekbom A (2002a) Supplementary oxygen and risk of childhood lymphatic leukaemia. Acta Paediatrica 91(12):1328–1333
Naumburg E, Bellocco R, Cnattinigius S, Jonzon A, Ekbom A (2002b) Perinatal exposure to infection and risk to childhood leukemia. Medical and Pediatric Oncology 38(6):391–397
Niemeyer C, Kratz C (2008) Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia: molecular classification and treatment options. British Journal of Haematology 140:610–624
O'Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F, Cornelissen JJ, Fisher T, Hochaus A, Hughes T, Lechner K,Nielsen JL, Rousselot P, Reiffers J, Saglio G, Shepherd J, Simonsson B, Gratwohl A, Goldman JM, Kantarjian H, Taylor K, Verhoef G, Bolton AE, Capdeville R, Druker BJ (2003)Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase myeloid leu kemia. New England Journal of Medicine 348(11):994–1004
Pang D, McNally R, Birch JM on behalf of the UK Childhood Cancer Study Investigators (2003) Parental smoking and childhood cancer: results from the United King-dom Childhood Cancer Study. British Journal of Cancer 88(3):373–381
Parker L, Cole M, Craft AW, Hey EN (1998) Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. British Medical Journal 316(7126):189–193
Passmore SJ, Draper G, Brownbill P, Kroll M (1998) Case-control studies of relation between childhood cancer and neonatal vitamin K administration. British Medical Journal 316(7126):178–184
Perea G, Lasa A, Aventin A, Domingo A, Villamor N, Queipo P, de Llano M, Llorente A, Junca J, Palacios C, Fernandez C, Gallart M, Font L, Tormo M, Florensa L, Bargay J, Vivancos P, Torres P, Berlanga JJ, Badell I, Brunet S, Sierra J,Nomdedeu JF (2006) Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics (t(8:21) and inv 16). Leukemia 20:87–94
Pieters R, Shrappe M, De Lorenzo P, Han I, De Rossi G, Felice M, Hovi L, Leblanc T, Szczepanski T, Ferster A, Janka F, Rubnitz J, Silverman L, Stary J, Campbell M, Li C, Mann G, Suppiah R, Biondi A, Vora A, Valseckli M (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant99):an observational study and a mulitcentre randomized trial. Lancet 370(9583):240–250
Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine 354(2): 166–178
Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro R, Razzouk B, Rubnitz J, Howard S, Hijiya N, Jeha S, Cheng C, Downing J, Evans W, Relling M, Hudson M (2005) Risk of adverse events after completion of therapy for childhood lymphoblastic leukemia. Journal of Clinical Oncology 23(31):7936–7941
Rech A, de Carvalho GP, Meneses CF, Hankins J, Howard S, Brunetto AL (2005) The influence of traumatic lumbar puncture and timing of intrathecal therapy on outcome of pediatric acute lymphoblastic leukemia. Pediatric Hema-tology and Oncology 22(6):483–488
Riberiro R (2006) Update of the management of pediatric acute promyelocytic leukemia. Clinical Advances in Hema-tology and Oncology 4(4):263–265
Roman E, Fear NT, Ansell P, Bull D, Draper G, McKinney P, Michaelis J, Passmore SJ, von Kries R (2002) Vitamin K and childhood cancer: analysis of individualpatient data from six case-control studies. British Journal of Cancer 86(1):63–69
Rosenbaum PF, Buck GM, Brecher ML (2005) Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatric Perinatal Epidemiology 19(2):152–164
Ross JA, Davies SM (2000) Vitamin Kprophylaxis and childhood cancer. Medical and Pediatric Oncology 34(6):434–437
Rubnitz J, Gibson B, Smith F (2008) Acute myeloid leukemia. Pediatric Clinics of North America 55:21–51
Ruccione KS,WaskerwitzM, Buckley J, Perin G, Hammond GD (1994) What caused my child's cancer? Parents' responses to an epidemiology study of childhood cancer. Journal of Pediatric Oncology Nursing 11(2):71–84
Rudant J, Menegaux F, Leverger G, Baruchel A, Lambilliotte A, Bertrand Y, Patte C, Pacquement H, Vérité C, Robert A, Michel G, Margueritte G, Gandemer V, Hémon D, Clavel J (2008) Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE). Cancer Causes & Control 19(10):1277–1290
Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y, Patte C, Pacquement H, Vérité C, Robert A, Michel G, Margueritte G, Gandemer V, Hémon D, Clavel J (2007) Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE). Environmental Health Perspectives 115(12):1787–1793
Ruggiero A, Ridola V, Puma N, Molinari F, Coccia P, De Rosa G, Riccardi R (2008) Anthracycline cardiotoxicity in childhood. Pediatric Hematology and Oncology 25(4):261–281
Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn RM, Wind-ebank KP (2009) Incidence and clinical features of langer-hans cell histiocytosis in the UK and Ireland. Archives of Disease in Childhood 94(5):376–380
Schultz K, Pullen J, Sather H, Shuster J, Devidas M, Borowitz M, Carroll A, Heerema N, Rubnitz J, Loh M, Raetz E, Winick N, Hunger S, Carroll W, Gaynon P, Camitta B (2007) Risk and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the pediatric oncology group (POG) and the childrens cancer group (CCG). Blood 109(3): 926–935
Schüz J, Svendsen AL, Linet MS, McBride ML, Roman E, Feychting M, Kheifets L, Lightfoot T, Mezei G, Simpson J, Ahlbom A (2007) Nighttime exposure to electromagnetic fields and childhood leukemia: an extended pooled analysis. American Journal of Epidemiology 166(3):263–269
Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J (2003) Atopic disease and childhood acute lymphoblastic leukemia. International Journal of Cancer 105(2):255–260
Sharathkumar A, Thornley I, Saunders EF, Calderwood S, Freedman MH, Doyle J (2002) Allogenic bone marrow transplantation in children with chronic myelogenous leukemia. Journal of Pediatric Hematology/Oncology 24(3): 215–219
Shu XO, Linet MS, Steinbuch M, Wen WQ, Buckley JD, Neglia JP, Potter JD, Reaman GH, Robison LL (1999) Breast feeding and risk of childhood acute leukemia. Journal of the National Cancer Institute 91(20):1765–1772
Skinner J, Mee TJ, Blackwell RP, Maslanyj MP, Simpson J, Allen SG, Day NE, Cheng KK, Gilman E, Williams D, Cart-wright R, Craft A, Birch JM, Eden OB, McKinney PA, Deacon J, Peto J, Beral V, Roman E, Elwood P, Alexander FE, Mott M, Chilvers CE, Muir K, Doll R, Taylor CM, Greaves M, Goodhead D, Fry FA, Adams G, Law G (2002) Exposure to power frequency electric fields and the risk of childhood cancer in the UK. British Journal of Cancer 87(11):1257–1266
Steinbach D, Lengemann J, Voigt A, Hermann J, Zintl F, Sauer-brey A (2003) Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia. Clinical Cancer Research 9(3):1083–1086
Stiller CA, Kroll ME, Boyle PJ, Feng Z (2008) Population mixing, socioeconomic status and incidence of childhood acute lymphoblastic leukaemia in England and Wales: analysis by census ward. British Journal of Cancer 98(5):1006–1011
Sung L, Bucktein R, Doyle JJ, Crump M, Detsky AS (2003) Treatment options for patients with acute myeloid leukemia with a matched sibling donor: a decision analysis. Cancer 97(3):592–600
Swensen AR, Ross JA, Shu XO, Reaman GH, Steinbuch M, Robison LL (2001) Pet ownership and childhood acute leukemia (USA and Canada). Cancer Causes & Control 12(4):301–303
Tomizawa D, Koh K, Sato T, Kinukawa N, Morimoto A, Isoyama K, Kosaka Y, Oda T, Oda M, Hayashi Y, Equali M, Horibe K, Nakahata T, Mizutansi S, Ishii E (2007) Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Group. Leukemia 21(11):2258–2263
Thapa PB, Whitlock JA, Brockman Worrell KG, Gideon P, Mitchel EF Jr, Roberson P, Pais R, Ray WA (1998) Prenatal exposure to metronidazole and risk of childhood cancer: a retrospective cohort study of children younger than 5 years. Cancer 83(7):1461–1468
UK Childhood Cancer Study Investigators (2001) Breastfeeding and childhood cancer. British Journal of Cancer 85(11):1685–1694
Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Dusenbery K, Kalousek D, Arthur DC, Lange BJ (1996) Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 87(12):4979–4989
Zwaan M, Reinhardt D, Hitzler J, Vyas P (2008) Acute leuke-mias in children with down syndrome. Pediatric Clinics of North America 55:53–70
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zupanec, S., Tomlinson, D. (2010). Leukemia. In: Tomlinson, D., Kline, N.E. (eds) Pediatric Oncology Nursing. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-87984-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-540-87984-8_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-87983-1
Online ISBN: 978-3-540-87984-8
eBook Packages: MedicineMedicine (R0)